World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
21865
World Ranking
13810
National Ranking
1281

Overview

Jeffrey M P Holly is affiliated with the University of Bristol in the United Kingdom. Their research primarily focuses on the field of Medicine, with specific involvement in Oncology and Pulmonary and Respiratory Medicine subfields.

The scientist's work addresses several topics including cancer survivorship and care, cancer risks and factors, and prostate cancer treatment and research.

  • Claire M. Perks (2 coauthored publications)
  • Lucy McGeagh (1 coauthored publication)
  • Luke Robles (1 coauthored publication)
  • Raj Persad (1 coauthored publication)
  • Edward Rowe (1 coauthored publication)

  • Pilot and Feasibility Studies (1 publication)
  • Endocrine Related Cancer (1 publication)

Recent publications include:

  • Prostate cancer-Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancer, 2022, Pilot and Feasibility Studies
  • ERRATUM: Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2, 2025, Endocrine Related Cancer

Best Publications

  • Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo.

    Vidya Mohamed-Ali;Steven Goodrick;Karen Bulmer;Jeffrey M. P. Holly

  • Height, Leg Length, and Cancer Risk: A Systematic Review

    D Gunnell;M Okasha;G D Smith;S E Oliver

  • Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.

    Andrew W. Roddam;Naomi E. Allen;Paul Appleby;Timothy J. Key

  • Circulating insulin‐like growth factor peptides and prostate cancer risk: A systematic review and meta‐analysis

    Mari-Anne Rowlands;David Gunnell;Ross Harris;Lars J. Vatten;Lars J. Vatten

  • Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight

    R M Freathy;D O Mook-Kanamori;U Sovio;I Prokopenko

  • Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner

    Zahidah P. Gill;Claire M. Perks;Paul V. Newcomb;Jeff M.P. Holly

  • The impact of childhood body mass index on timing of puberty, adult stature and obesity: a follow-up study based on adolescent anthropometry recorded at Christ's Hospital (1936-1964)

    JS Sandhu;Y Ben-Shlomo;TJ Cole;Jmp Holly

  • Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments

    J. M. P. Holly;J. A. H. Wass

  • The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness.

    S. C. Davies;J. A. H. Wass;R. J. M. Ross;A. M. Cotterill

  • Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease

    Andrew C. Frca Timmins;Andrew M. Cotterill;Sian C. Cwyfan Hughes;Jeff M. P. Holly

  • Growth hormone, insulinlike growth factor‐1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease

    Anthony Donaghy;Richard Ross;Alexander Gimson;Sian Cwyfan Hughes

  • Circulating Levels of Insulin-like Growth Factors, their Binding Proteins, and Breast Cancer Risk

    Eva S Schernhammer;Jeff M Holly;Michael N Pollak;Susan E Hankinson

  • A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations.

    Timothy M. Frayling;Andrew T. Hattersley;Anne McCarthy;Jeff Holly

  • Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin?

    Jeffrey M P Holly;R A Biddlecombe;D B Dunger;J A Edge

  • The role of insulin-like growth factor binding proteins.

    Jeff Holly;Claire Perks

  • The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics.

    A M Taylor;D B Dunger;M A Preece;Jeffrey M P Holly

  • Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II

    Eva S Schernhammer;Jeff M Holly;David J Hunter;Michael N Pollak

  • Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily.

    R. C. Baxter;M. A. Binoux;D. R. Clemmons;C. A. Conover

  • Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome.

    Gerard S. Conway;H. S. Jacobs;J. M. P. Holly;J. A. H. Wass

  • Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review.

    Olivia Fletcher;Lorna Gibson;Nichola Johnson;Dan R Altmann

Frequent Co-Authors

Richard M. Martin
Richard M. Martin University of Bristol
David Gunnell
David Gunnell University of Bristol
David B. Dunger
David B. Dunger University of Cambridge
Jenny L Donovan
Jenny L Donovan University of Bristol
David E. Neal
David E. Neal University of Cambridge
Freddie C. Hamdy
Freddie C. Hamdy University of Oxford
George Davey Smith
George Davey Smith University of Bristol
Yoav Ben-Shlomo
Yoav Ben-Shlomo University of Bristol
Graham G. Giles
Graham G. Giles University of Melbourne
Per Eystein Lønning
Per Eystein Lønning Haukeland University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine offers a range of educational opportunities beyond the traditional MD pathway. Many students begin with nursing, and online programs have made this more accessible than ever. Those looking for affordable options can explore the cheapest bsn programs to help advance from an RN to a BSN without taking on heavy debt.

For individuals interested in becoming nurse practitioners but who do not have a nursing background, direct entry nurse practitioner programs for non-nurses online offer a streamlined path to this rewarding field.

Students seeking a quicker or more accessible entry point into nursing might consider adn programs, which can be less competitive and can get you started in healthcare sooner.

Additionally, there are allied health pathways, such as medical billing and coding, which can be pursued online. Financial support is often available—see financial aid for medical billing and coding online classes for more information on how you can secure assistance for your studies.

Best Scientists Citing Jeffrey M P Holly

Trending Scientists

Recently Published Articles